Enter your login e-mail to the account
Search
- Cognitive impairment in multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2015, Review articles ) - Role of T and B cells in pathogenesis of multiple sclerosis
prof. RNDr. Jan Krejsek, CSc., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(2/2016, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Adherence to treatment in multiple sclerosis: case reports of three female patients on high-efficacy therapy with ocrelizumab
MUDr. Jana Pavlíčková, Ph.D.
(3/2024, Case reports ) - Hepatic impairment during the treatment multiple sclerosis by dimethyl-fumarate
MUDr. Květoslava Aiglová, Ph.D., prof. MUDr. Jiří Ehrmann, CSc.
(5/2018, From the boundary of neurology ) - Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis
MUDr. Eva Meluzínová
(4/2014, Review articles ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Multiple sclerosis: dimethyl fumarate and fingolimod – from clinical trials to clinical practice
Doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek, PhD.
(6/2017, Pharmacotherapy ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic )
- New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )